Given the role of IDO1 and IL-1β in TB pathogenesis, this suggests therefore that both of these genes could be considered potential biomarkers for TB infection and could lead to an exciting possibility for the development of novel host-directed TB interventions. This evidence concerns the gene IL1B and tuberculosis.